# Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

> **NCT01101984** · NA · COMPLETED · sponsor: **Santen Pharmaceutical Co., Ltd.** · enrollment: 400 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** diquafosol ophthalmic solution
- **DRUG:** 0.1% sodium hyaluronate ophthalmic solution.

## Key facts

- **NCT ID:** NCT01101984
- **Lead sponsor:** Santen Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** —
- **Final completion:** 2012-04
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101984, "Study of DE-089 Ophthalmic Solution in Patients With Dry Eye". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01101984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*